Assessing factors for loss to follow-up of HIV infected patients in Guinea-Bissau
The objective of this study was to ascertain vital status of patients considered lost to follow-up at an HIV clinic in Guinea-Bissau, and describe reasons for loss to follow-up (LTFU).
This study was a cross-sectional sample of a prospective cohort, carried out between May 15, 2013, and January 31, 2014. Patients lost to follow-up, who lived within the area of the Bandim Health Project, a demographic surveillance site (DSS), were eligible for inclusion. Active follow-up was attempted by telephone and tracing by a field assistant. Semi-structured interviews were done face to face or by phone by a field assistant and patients were asked why they had not shown up for the scheduled appointment. Patients were included by date of HIV testing and risk factors for LTFU were assessed using Cox proportional hazard model.
Among 561 patients (69.5 % HIV-1, 18.0 % HIV-2 and 12.6 % HIV-1/2) living within the DSS, 292 patients had been lost to follow-up and were, therefore, eligible for active follow-up. Vital status was ascertained in 65.9 % of eligible patients and 42.7 % were alive, while 23.2 % had died. Information on reasons for LTFU existed for 103 patients. Major reasons were moving (29.1 %), travelling (17.5 %), and transferring to other clinics (11.7 %).
A large proportion of the patients at the clinic were lost to follow-up. The main reason for this was found to be the geographic mobility of the population in Guinea-Bissau.
KeywordsHIV Loss to follow-up Retention Mortality West Africa Guinea-Bissau
The authors would like to thank the staff and patients at the HIV clinic. Special thanks to João Paulo Nanque, Joana Mendes and Quintino Lopes Ié for their work with tracing patients and to Zacarias da Silva and the laboratory staff working in the TB and HIV sections at the National Public Health Laboratory and to the office staff at the Bandim Health Project for making this study possible.
The Bissau HIV Cohort study group comprises: Amabelia Rodrigues, David da Silva, Zacarias da Silva, Candida Medina, Ines Oliviera-Souto, Lars Østergaard, Alex Laursen, Bo Hønge, Peter Aaby, Anders Fomsgaard, Christian Erikstrup, Sanne Jespersen and Christian Wejse (chair).
Funding was provided by Institut for Klinisk Medicin, and National Institutes of Health (Grant No. U01AI069919) through IeDEA.
Compliance with ethical standards
The HIV cohort at the outpatient clinic was approved by the National Ethics Committee in Guinea-Bissau in 2007 (Parecer NCP/No. 15/2007). Upon inclusion, patients sign a voluntary, informed consent, using fingerprint if illiterate. The cohort has an open approval to use data from patients’ records as long as patient confidentiality is not broken. This study was approved separately by the ethical committee in Guinea-Bissau (No. Ref. 060/CNES/INASA/2013). At all times field assistants were cautious not to disclose HIV status to anyone.
Conflict of interest
PBN has received funding from Institute of Clinical Medicine, Aarhus University, Denmark. WAPHIR and IeDEA supported data collection in Bissau. For the remaining authors none were declared.
- 1.WHO/UNICEF/UNAIDS. Global update on HIV treatment 2013: results, impact and opportunities. Geneva: World Health Organization; 2013.Google Scholar
- 2.Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med. 2011;155:209–16. doi: 10.7326/0003-4819-155-4-201108160-00358.CrossRefPubMedGoogle Scholar
- 4.Loutfy MR, Wu W, Letchumanan M, Bondy L, Antoniou T, Margolese S, et al. Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy. PLoS One. 2013;8:e55747. doi: 10.1371/journal.pone.0055747.CrossRefPubMedPubMedCentralGoogle Scholar
- 6.Jean K, Gabillard D, Moh R, Danel C, Fassassi R, Desgrees-du-Lou A, et al. Effect of early antiretroviral therapy on sexual behaviors and HIV-1 transmission risk among adults with diverse heterosexual partnership statuses in Cote d’Ivoire. J Infect Dis. 2014;209:431–40. doi: 10.1093/infdis/jit470.CrossRefPubMedGoogle Scholar
- 7.WHO/UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2012. Geneva: World Health Organization; 2012.Google Scholar
- 8.WHO/UNAIDS. UNAIDS World AIDS Day Report Results. Geneva: World Health Organization; 2012. p. 2012.Google Scholar
- 9.UNAIDS. GAP report: HIV estimates with uncertainty bounds 1990–2012. http://www.unaids.org/en/dataanalysis/knowyourepidemic/epidemiologypublications/. Accessed 22 April 2014.
- 14.Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, Grosskurth H, et al. Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health. 2009;9:290. doi: 10.1186/1471-2458-9-290.CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Togun T, Peterson I, Jaffar S, Oko F, Okomo U, Peterson K, et al. Pre-treatment mortality and loss-to-follow-up in HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients eligible for antiretroviral therapy in The Gambia, West Africa. AIDS Res Ther. 2011;8:24. doi: 10.1186/1742-6405-8-24.CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Bastard M, Nicolay N, Szumilin E, Balkan S, Poulet E, Pujades-Rodriguez M. Adults receiving HIV care before the start of antiretroviral therapy in sub-Saharan Africa: patient outcomes and associated risk factors. J Acquir Immune Defic Syndr. 2013;64:455–63. doi: 10.1097/QAI.0b013e3182a61e8d.CrossRefPubMedGoogle Scholar
- 23.Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, Yiannoutsos CT, et al. Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr. 2010;53:405–11. doi: 10.1097/QAI.0b013e3181b843f0.CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Mugglin C, Estill J, Wandeler G, Bender N, Egger M, Gsponer T, et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health. 2012;17:1509–20. doi: 10.1111/j.1365-3156.2012.03089.x.CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Asiimwe SB, Kanyesigye M, Bwana B, Okello S, Muyindike W. Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa. BMC Infect Dis. 2016;16:43. doi: 10.1186/s12879-016-1392-7.CrossRefPubMedPubMedCentralGoogle Scholar
- 29.Honge BL, Jespersen S, Nordentoft PB, Medina C, da Silva D, da Silva ZJ, et al. Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort study. BMJ Open. 2013;3:e003499. doi: 10.1136/bmjopen-2013-003499.CrossRefPubMedPubMedCentralGoogle Scholar
- 30.The official Bandim Health Project website. http://www.bandim.org/about-bhp.aspx. Accessed April 2014.
- 31.Chi BH, Yiannoutsos CT, Westfall AO, Newman JE, Zhou J, Cesar C, et al. Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America. PLoS Med. 2011;8:e1001111. doi: 10.1371/journal.pmed.1001111.CrossRefPubMedPubMedCentralGoogle Scholar
- 34.Marson KG, Tapia K, Kohler P, McGrath CJ, John-Stewart GC, Richardson BA, et al. Male, mobile, and moneyed: loss to follow-up vs. transfer of care in an urban African antiretroviral treatment clinic. PLoS One. 2013;8:e78900. doi: 10.1371/journal.pone.0078900.CrossRefPubMedPubMedCentralGoogle Scholar
- 37.Lubega M, Musenze IA, Joshua G, Dhafa G, Badaza R, Bakwesegha CJ, et al. Sex inequality, high transport costs, and exposed clinic location: reasons for loss to follow-up of clients under prevention of mother-to-child HIV transmission in eastern Uganda–a qualitative study. Patient Preference Adherence. 2013;7:447–54. doi: 10.2147/ppa.s19327.CrossRefPubMedPubMedCentralGoogle Scholar
- 39.Torpey KE, Kabaso ME, Mutale LN, Kamanga MK, Mwango AJ, Simpungwe J, et al. Adherence support workers: a way to address human resource constraints in antiretroviral treatment programs in the public health setting in Zambia. PLoS One. 2008;3:e2204. doi: 10.1371/journal.pone.0002204.CrossRefPubMedPubMedCentralGoogle Scholar